Study of Weekly Cabazitaxel for Advanced Prostate Cancer
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This is a multicenter open label non randomized phase II clinical trial of Weekly Cabazitaxel
for Advanced Prostate Cancer in Hormone-Refractory Patients Previously Treated with
Docetaxel.
The purpose of this study is to evaluate the activity of the weekly administration of
cabazitaxel as time to progression by PSA at week 12.